Company
Colospan
Colospan has developed CG-100, a breakthrough solution for colorectal surgery that aims to improve the clinical and financial outcomes associated with anastomotic leaks and diverting stomas
- Status
- Acquiredas of 2026-09-18Source (opens in a new tab)
- Business model
- B2B
- Customers
- Payers & Providers
Claim, correct or request removal
Record updated 18 September 2026
About
CG-100 is a CE marked intraluminal bypass made of soft silicone, placed through the anus to protect the surgical site after colorectal surgery.
Funding snapshot
- Total raised
- $9.3MSum of rounds, as of 2026-09-18Source (opens in a new tab)
- Latest round
- Grant, $9.3M2021-12-23
Funding rounds
- Grant
- $9.3M2021-12-23, Company stated
About the company
- Status notes
- Galmed Pharmaceuticals to Acquire Colospan to Create a GI-Focused Platform Targeting a $6 Billion Market
Products
- Hardware
- CG-100
Exit
- Acquisition
- 2026-06-08
Loading relationship preview